Clinical Trials Browser

Phase 2 × Colonic Neoplasms × tipiracil × Clear all

NCT07085169 2025-07-25

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms